Cove Street Capital’s AbbVie ABBV Stock Holding History

Cove Street Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$185K	Hold	800	–	–	0.24%	52
2025 Q2	$148K	Sell	800 -200	-20%	-$37.2K	0.22%	57
2025 Q1	$210K	Hold	1,000	–	–	0.33%	49
2024 Q4	$178K	Hold	1,000	–	–	0.21%	51
2024 Q3	$197K	Hold	1,000	–	–	0.15%	56
2024 Q2	$172K	Hold	1,000	–	–	0.12%	55
2024 Q1	$182K	Hold	1,000	–	–	0.06%	54
2023 Q4	$155K	Hold	1,000	–	–	0.05%	56
2023 Q3	$149K	Hold	1,000	–	–	0.05%	65
2023 Q2	$135K	Hold	1,000	–	–	0.04%	66
2023 Q1	$159K	Hold	1,000	–	–	0.05%	64
2022 Q4	$162K	Hold	1,000	–	–	0.04%	65
2022 Q3	$134K	Hold	1,000	–	–	0.04%	64
2022 Q2	$153K	Hold	1,000	–	–	0.04%	66
2022 Q1	$162K	Sell	1,000 -300	-23%	-$43.6K	0.03%	69
2021 Q4	$176K	Hold	1,300	–	–	0.03%	71
2021 Q3	$140K	Hold	1,300	–	–	0.02%	76
2021 Q2	$146K	Sell	1,300 -200	-13%	-$22.5K	0.02%	76
2021 Q1	$162K	Hold	1,500	–	–	0.02%	72
2020 Q4	$161K	Hold	1,500	–	–	0.03%	64
2020 Q3	$131K	Hold	1,500	–	–	0.02%	62
2020 Q2	$147K	Hold	1,500	–	–	0.03%	63
2020 Q1	$114K	Hold	1,500	–	–	0.02%	94
2019 Q4	$133K	Hold	1,500	–	–	0.02%	95
2019 Q3	$114K	Hold	1,500	–	–	0.02%	92
2019 Q2	$109K	Hold	1,500	–	–	0.01%	93
2019 Q1	$121K	Hold	1,500	–	–	0.01%	93
2018 Q4	$138K	Hold	1,500	–	–	0.02%	92
2018 Q3	$142K	Hold	1,500	–	–	0.02%	90
2018 Q2	$139K	Hold	1,500	–	–	0.02%	94
2018 Q1	$142K	Hold	1,500	–	–	0.02%	101
2017 Q4	$145K	Hold	1,500	–	–	0.02%	100
2017 Q3	$133K	Buy	+1,500	New	+$114K	0.01%	102

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cove Street Capital's ABBV Position: Q3 2025 in Review

Cove Street Capital held its AbbVie (ABBV) position steady in Q3 2025 at 800 shares worth $185K. The position accounts for 0.24% of the portfolio, ranked #52.

Cove Street Capital first reported a position in ABBV in Q3 2017 and has held it in 33 quarters since. The position peaked at $210K in Q1 2025. 3,915 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

Cove Street Capital held 800 shares of AbbVie worth $185K as of Q3 2025.
Cove Street Capital left its AbbVie share count unchanged in Q3 2025.
AbbVie made up 0.24% of Cove Street Capital's portfolio in Q3 2025, its #52 holding.
Cove Street Capital first reported a position in AbbVie in Q3 2017 and has held it in 33 quarters since.
Cove Street Capital's AbbVie position peaked at $210K in Q1 2025.
3,915 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Cove Street Capital's 13F filing for Q3 2025, filed 13 Nov 2025.